Patient Square adds to investment team

Menlo Park, California-based Patient Square Capital named Alex Albert and Neel Varshney, M.D., as founding partners in a bid to continue to grow its dedicated healthcare investment firm. Albert previously was at Ares Management, where he served as partner and co-head of health care within the private equity group. Varshney was at KKR and served as managing director within the Americas Health Care Team. The pair join Patient Square Managing Partner Jim Momtazee, Founding Partner and CFO Maria Walker, and Founding Partner and General Counsel Adam Fliss. Momtazee spent over 21 years at KKR and helped establish its health care group in 2001. He worked with Albert, who was at KKR earlier in his career. "Having worked closely with both Alex and Neel in the past, I am thrilled to partner with them again. I know firsthand that their deep health care and investing experience will help us in our goal to establish Patient Square Capital as the preeminent health care investment firm," said Momtazee. "Alex and Neel bring distinct and complementary skills and experiences, underpinned by a shared mission to deliver for investors and to invest with the well-being of patients as a top priority." Momtazee formed Patient Square in 2020, with an aim to seek opportunities to invest broadly across the health care industry, including technology-enabled services, biopharmaceuticals, the pharmaceutical value chain, medical devices, diagnostics, providers, digital health and consumer health. Among the major health care investments made during Momtazee’s tenure at KKR was Jazz Pharmaceuticals (2004); HCA (2006), a $33 billion transaction which at the time was the largest cash buyout in history; PRA Health Sciences (2013); and BridgeBio Pharma (2016). Mr. Momtazee currently serves on the Boards of Directors of BridgeBio, PRA Health Sciences (lead independent director), and the Medical Device Manufacturers Association. "I am excited to join Jim and our other partners at Patient Square Capital," said Albert. "Having known Jim personally and professionally for over a dozen years, we are aligned as a team in our approach to investing and we have a shared conviction around the opportunity that exists to create a scaled and specialized health care investment firm purpose-built to partner with world-class companies and management teams." "As a physician and investor, I believe passionately in the power of this firm, and the companies and people we partner with, to have a positive and meaningful impact on the lives of patients," said Varshney. "Now is a transformative time for health care with unprecedented opportunities to innovate and improve efficiency, and I am excited for the significant role that Patient Square Capital can play."

Continue Reading With a Free Trial

Be an Alts Watcher

Subscribe to our mailing list and know first!

FoHFs Optima outlines key interests in Asia, healthcare and long/short strategies

New alts venture for former Permal and EnTrust investment duo

Related Articles

MassPRIM plots $18bn diverse asset manager program

Yale’s Swensen remembered as an alternative investing pioneer

Preparing your hedge fund for the modern cybercriminal

Barometer Capital launches Canadian music rights fund

Get our daily news digest in your inbox

Get our daily news digest
in your inbox